| |
| |
|
| Insider
Information: |
Yu K Peony |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
195,078 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$349,713 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
195,078 |
|
|
| Total
Value |
$349,713 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fibrogen Inc |
FGEN |
Chief Medical Officer |
2020-12-16 |
192,292 |
|
0 |
Premium* |
|
|
STAAR Surgical Co |
STAA |
Director |
2023-06-15 |
2,786 |
2020-01-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
102 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2014-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
171,000 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical DevelopmentOffice |
• – – |
2014-11-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
143,000 |
|
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
32,068 |
203,068 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-05-14 |
4 |
D |
$21.39 |
$58,010 |
D/D |
(2,712) |
202,692 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-05-15 |
4 |
OE |
$2.90 |
$25,600 |
D/D |
8,000 |
210,692 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-06-01 |
4 |
D |
$17.50 |
$11,498 |
D/D |
(657) |
210,035 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-07-06 |
4 |
AS |
$22.56 |
$122,097 |
D/D |
(5,381) |
204,654 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-09-01 |
4 |
D |
$22.84 |
$15,006 |
D/D |
(657) |
203,997 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-09-10 |
4 |
AS |
$27.84 |
$30,430 |
D/D |
(1,093) |
202,904 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-10-15 |
4 |
AS |
$20.50 |
$51,250 |
D/D |
(2,500) |
200,404 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-10-16 |
4 |
AS |
$22.42 |
$56,050 |
D/D |
(2,500) |
197,904 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-10-19 |
4 |
AS |
$24.00 |
$120,000 |
D/D |
(5,000) |
192,904 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-11-09 |
4 |
AS |
$25.00 |
$62,500 |
D/D |
(2,500) |
190,404 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-11-10 |
4 |
AS |
$26.23 |
$65,575 |
D/D |
(2,500) |
187,904 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-11-17 |
4 |
AS |
$28.00 |
$140,000 |
D/D |
(5,000) |
183,345 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-11-25 |
4 |
AS |
$30.00 |
$10,320 |
D/D |
(344) |
183,001 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-11-30 |
4 |
AS |
$30.00 |
$139,680 |
D/D |
(4,656) |
178,345 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-12-01 |
4 |
D |
$29.88 |
$19,631 |
D/D |
(657) |
177,688 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2015-12-10 |
4 |
AS |
$28.96 |
$31,653 |
D/D |
(1,093) |
176,595 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2016-02-05 |
4 |
OE |
$3.50 |
$47,775 |
D/D |
10,500 |
187,095 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2016-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
35,294 |
222,389 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
VP, Clinical Development |
• – – |
2016-03-03 |
4 |
D |
$18.77 |
$68,698 |
D/D |
(3,660) |
218,729 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Chief Medical Officer |
• – – |
2016-05-16 |
4 |
AS |
$17.60 |
$107,483 |
D/D |
(6,107) |
214,011 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Chief Medical Officer |
• – – |
2016-06-01 |
4 |
D |
$18.89 |
$26,635 |
D/D |
(1,410) |
212,601 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Chief Medical Officer |
• – – |
2016-06-10 |
4 |
AS |
$17.96 |
$42,098 |
D/D |
(2,344) |
210,257 |
0 |
- |
|
102 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
